Janssen Pharmaceutical Cos.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Janssen Pharmaceutical Cos.
Proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
However, recruitment for adult trials remains robust, OWS’ Slaoui says.
A number of companies have sought to convince the European Medicine Agency that their drug merits a fast-track regulatory review.
The US missed even its revised year-end target for COVID vaccines, but the news isn’t all bad; there’s steady progress on clinical research even as federal officials seem out of ideas for how to speed actual vaccinations.